![](/img/cover-not-exists.png)
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia – real-world resource use data
Lecat, Catherine S. Y., Besley, Caroline, Hough, Rachael E., Khwaja, Asim, Furness, Caroline, Marks, David I., Fielding, Adele K.Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2019.1672057
Date:
October, 2019
File:
PDF, 716 KB
2019